<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2016-4-56-63</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-78</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БОЛЕЗНИ ДЫХАТЕЛЬНЫХ ПУТЕЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESPIRATORY TRACT DISEASES</subject></subj-group></article-categories><title-group><article-title>Диагностика и рациональная антибактериальная терапия А-стрептококковых инфекций глотки как основа первичной профилактики острой ревматической лихорадки</article-title><trans-title-group xml:lang="en"><trans-title>Diagnosis and rational antibiotic therapy of group A streptococcal infections as the basis for the primary prevention of acute rheumatic fever</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белов</surname><given-names>Б. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Belov</surname><given-names>B. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Научно-исследовательский институт ревматологии им. В.А. Насоновой<country>Россия</country></aff><aff xml:lang="en">Nasonova Research Institute of Rheumatology<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2016</year></pub-date><volume>0</volume><issue>4</issue><fpage>56</fpage><lpage>63</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Белов Б.С., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Белов Б.С.</copyright-holder><copyright-holder xml:lang="en">Belov B.S.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/78">https://www.med-sovet.pro/jour/article/view/78</self-uri><abstract><p>Проблема острого тонзиллита, вызванного р-гемолитическим стрептококком группы А (БГСА), по-прежнему сохраняет свою актуальность как во врачебном, так и в общемедицинском плане. В настоящей статье представлены данные, свидетельствующие о возрождении высоковирулентной БГСА-инфекции и нарастании частоты осложнений (острая ревматическая лихорадка, синдром токсического шока), обоснована необходимость рациональной антибактериальной терапии данной патологии. Препаратами выбора для лечения острых форм БГСА-тонзиллита являются пенициллины (амоксициллин, бензатин-пенициллин, феноксиметилпенициллин) и цефалоспорины I поколения (цефадроксил), а при непереносимости р-лактамных антибиотиков - макролиды. При наличии хронического рецидивирующего БГСА- тонзиллита, когда вероятность колонизации очага инфекции микроорганизмами, продуцирующими р-лактамазы, достаточно высока, применяют ингибитор-защищенные пенициллины (амоксициллин-клавуланат) или цефалоспорины II-III поколения (цефу-роксим-аксетил, цефиксим). Антибиотики - линкозамины (линкомицин, клиндамицин) используют в терапии острого и хронического БГСА- тонзиллита как препараты резерва.</p></abstract><trans-abstract xml:lang="en"><p>Acute tonsillitis caused by group A b-hemolytic streptococcus (GABHS) remains a challenge both for doctors and the healthcare in general. The article provides evidence of the revival of the highly virulent GABHS infection and the growing incidence of complications (acute rheumatic fever, toxic shock syndrome), and substantiates the need for rational antibiotic therapy of the disease. The drugs of choice for the treatment of acute GABHS tonsillitis are penicillins (amoxicillin, benzathine penicillin, phenoxymethylpenicillin) and 1st-generation cephalosporins (cefadroxil), and, in case of intolerance, b-lactam antibiotics - macrolides. In case of chronic recurrent GABHS tonsillitis, when the risk of colonization of the focal point by microorganisms producing b-lactamase is quite high, inhibitor-protected penicillins (amoxicillin-clavulanate) or 2nd- or 3rd-generation cephalosporins (cefuroxime axetil, cefixime) are administered. Lincosamides (lincomycin, clindamycin) are used in the treatment of acute and chronic GABHS tonsillitis as reserve antibiotics.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>А-стрептококковый тонзиллит</kwd><kwd>антибиотикотерапия</kwd><kwd>A streptococcal tonsillitis</kwd><kwd>antibiotic treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation, 2009, 119(11): 1541-51.</mixed-citation><mixed-citation xml:lang="en">Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation, 2009, 119(11): 1541-51.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, Remenyi B, Taubert KA, Bolger AF, Beerman L, Mayosi BM, Beaton A, Pandian NG, Kaplan EL; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation, 2015, 131(20): 1806-18.</mixed-citation><mixed-citation xml:lang="en">Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, Remenyi B, Taubert KA, Bolger AF, Beerman L, Mayosi BM, Beaton A, Pandian NG, Kaplan EL; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation, 2015, 131(20): 1806-18.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis, 2012, 55(10): e86-102.</mixed-citation><mixed-citation xml:lang="en">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis, 2012, 55(10): e86-102.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Насонова В.А., Белов Б.С., Страчунский Л.С., Каманин Е.И., Богданович Т.М., Судиловская Н.Н., Кречикова О.И., Богомильский М.Р., Овчинников Ю.М. Антибактериальная терапия стрептококкового тонзиллита и фарингита. Клин. микробиол. антимикроб. тер. 1999; 1: 78-82.</mixed-citation><mixed-citation xml:lang="en">Насонова В.А., Белов Б.С., Страчунский Л.С., Каманин Е.И., Богданович Т.М., Судиловская Н.Н., Кречикова О.И., Богомильский М.Р., Овчинников Ю.М. Антибактериальная терапия стрептококкового тонзиллита и фарингита. Клин. микробиол. антимикроб. тер. 1999; 1: 78-82.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child, 1972, 124: 352-358.</mixed-citation><mixed-citation xml:lang="en">Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child, 1972, 124: 352-358.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pfoh E, Wessels MR, Goldmann D, Lee GM. Burden and economic cost of group A strepto-coccal pharyngitis. Pediatrics, 2008, 121(2): 229-34.</mixed-citation><mixed-citation xml:lang="en">Pfoh E, Wessels MR, Goldmann D, Lee GM. Burden and economic cost of group A strepto-coccal pharyngitis. Pediatrics, 2008, 121(2): 229-34.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Беляков В.Д. Сюрпризы стрептококковой инфекции. Вестн. РАМН, 1996, 11: 24-28.</mixed-citation><mixed-citation xml:lang="en">Беляков В.Д. Сюрпризы стрептококковой инфекции. Вестн. РАМН, 1996, 11: 24-28.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Pastore S, De Cunto A, Benettoni A, Berton E, Taddio A, Lepore L. The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology, 2011, 50(2): 396-400.</mixed-citation><mixed-citation xml:lang="en">Pastore S, De Cunto A, Benettoni A, Berton E, Taddio A, Lepore L. The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology, 2011, 50(2): 396-400.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vinker S, Zohar E, Hoffman R, Elhayany A.Incidence and clinical manifestations of rheumatic fever: a 6 year community-based survey. Isr Med Assoc J, 2010, 12(2): 78-81.</mixed-citation><mixed-citation xml:lang="en">Vinker S, Zohar E, Hoffman R, Elhayany A.Incidence and clinical manifestations of rheumatic fever: a 6 year community-based survey. Isr Med Assoc J, 2010, 12(2): 78-81.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol, 2011, 22(3): 67-84.</mixed-citation><mixed-citation xml:lang="en">Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol, 2011, 22(3): 67-84.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mclsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ, 2000, 163(7): 811-815.</mixed-citation><mixed-citation xml:lang="en">Mclsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ, 2000, 163(7): 811-815.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr, 2011 Jan 31, 37: 10.</mixed-citation><mixed-citation xml:lang="en">Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr, 2011 Jan 31, 37: 10.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chiappini E, Regoli M, Bonsignori F, Sollai S, Parretti A, Galli L, de Martino M. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther, 2011, 33(1): 48-58.</mixed-citation><mixed-citation xml:lang="en">Chiappini E, Regoli M, Bonsignori F, Sollai S, Parretti A, Galli L, de Martino M. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther, 2011, 33(1): 48-58.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chovel-Sella A, Ben Tov A, Lahav E, Mor O, Rudich H, Paret G, Reif S. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics, 2013, 131(5): e1424-7.</mixed-citation><mixed-citation xml:lang="en">Chovel-Sella A, Ben Tov A, Lahav E, Mor O, Rudich H, Paret G, Reif S. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics, 2013, 131(5): e1424-7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Casey JR, Pichichero ME. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. Clin Infect Dis, 2005, 40(12): 1748-55.</mixed-citation><mixed-citation xml:lang="en">Casey JR, Pichichero ME. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. Clin Infect Dis, 2005, 40(12): 1748-55.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Altamimi S, Khalil A, Khalaiwi KA, Milner R, Pusic MV, Al Othman MA. Short versus standard duration antibiotic therapy for acute strepto-coccal pharyngitis in children. Cochrane Database Syst Rev, 2009, (1): CD004872.</mixed-citation><mixed-citation xml:lang="en">Altamimi S, Khalil A, Khalaiwi KA, Milner R, Pusic MV, Al Othman MA. Short versus standard duration antibiotic therapy for acute strepto-coccal pharyngitis in children. Cochrane Database Syst Rev, 2009, (1): CD004872.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis, 2006, 43(11): 1398-406.</mixed-citation><mixed-citation xml:lang="en">Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis, 2006, 43(11): 1398-406.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fiedler T, Koller T, Kreikemeyer B. Streptococcus pyogenes biofilms - formation, biology, and clinical relevance. Front Cell Infect Microbiol Published online: 11 February 2015.</mixed-citation><mixed-citation xml:lang="en">Fiedler T, Koller T, Kreikemeyer B. Streptococcus pyogenes biofilms - formation, biology, and clinical relevance. Front Cell Infect Microbiol Published online: 11 February 2015.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shen Y, Koller T, Kreikemeyer B, Nelson DC. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. J Antimicrob Chemother, 2013, 68(8): 1818-24.</mixed-citation><mixed-citation xml:lang="en">Shen Y, Koller T, Kreikemeyer B, Nelson DC. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. J Antimicrob Chemother, 2013, 68(8): 1818-24.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Азитромицин и биопленки. Данные на сайте: www.antibiotic.ru/forum.php? t=930.</mixed-citation><mixed-citation xml:lang="en">Азитромицин и биопленки. Данные на сайте: www.antibiotic.ru/forum.php? t=930.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Азовскова О.В., Иванчик Н.В., Дехнич А.В., Кречикова О.И. , Козлов Р.С. , исследовательская группа «ПеГАС». Динамика антибиотико-резистентности респираторных штаммов Streptococcus pyogenes в России за период 1999-2009 гг. Клин Микробиол Антимикроб Химиотер, 2012, 14(4): 309-321.</mixed-citation><mixed-citation xml:lang="en">Азовскова О.В., Иванчик Н.В., Дехнич А.В., Кречикова О.И. , Козлов Р.С. , исследовательская группа «ПеГАС». Динамика антибиотико-резистентности респираторных штаммов Streptococcus pyogenes в России за период 1999-2009 гг. Клин Микробиол Антимикроб Химиотер, 2012, 14(4): 309-321.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Logan LK, McAuley JB, Shulman ST. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics, 2012, 129(3): e798-802.</mixed-citation><mixed-citation xml:lang="en">Logan LK, McAuley JB, Shulman ST. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics, 2012, 129(3): e798-802.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Feinstein AR, Wood HF, Epstein JA, Taranta A, Simpson R, Tursky E.A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis. N Engl J Med, 1959, 260(14): 697-702.</mixed-citation><mixed-citation xml:lang="en">Feinstein AR, Wood HF, Epstein JA, Taranta A, Simpson R, Tursky E.A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis. N Engl J Med, 1959, 260(14): 697-702.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">McNeil SA, Halperin SA, Langley JM et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis, 2005, 41: 1114-1122.</mixed-citation><mixed-citation xml:lang="en">McNeil SA, Halperin SA, Langley JM et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis, 2005, 41: 1114-1122.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bisno AL. Acute rheumatic fever: a present-day perspective. Medicine, 1993, 72(4): 278-283.</mixed-citation><mixed-citation xml:lang="en">Bisno AL. Acute rheumatic fever: a present-day perspective. Medicine, 1993, 72(4): 278-283.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Nasonova V.A., Belov B.S., Stratchounskiy L.S., Kamanin E.I., Bogdanovich T.M., Sudilovskaya N.N., Krechikova O.I., Bogomilsky M.R., Ovchinnikov Y.M. Antibiotic treatment of streptococcal tonsillitis and pharyngitis. Klin. Mikrobiol. Antimikrob. Ter. 1999; 1: 78-82.</mixed-citation><mixed-citation xml:lang="en">Nasonova V.A., Belov B.S., Stratchounskiy L.S., Kamanin E.I., Bogdanovich T.M., Sudilovskaya N.N., Krechikova O.I., Bogomilsky M.R., Ovchinnikov Y.M. Antibiotic treatment of streptococcal tonsillitis and pharyngitis. Klin. Mikrobiol. Antimikrob. Ter. 1999; 1: 78-82.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child, 1972, 124: 352-358.</mixed-citation><mixed-citation xml:lang="en">Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child, 1972, 124: 352-358.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Pfoh E, Wessels MR, Goldmann D, Lee GM. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics</mixed-citation><mixed-citation xml:lang="en">Pfoh E, Wessels MR, Goldmann D, Lee GM. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Belyakov V.D. Surprises of streptococcal infection. Vestnik RAMN, 1996, 11: 24-28.</mixed-citation><mixed-citation xml:lang="en">Belyakov V.D. Surprises of streptococcal infection. Vestnik RAMN, 1996, 11: 24-28.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Azithromycin and biofilms. Data on the site: www.antibiotic.ru/forum.php? t=930.</mixed-citation><mixed-citation xml:lang="en">Azithromycin and biofilms. Data on the site: www.antibiotic.ru/forum.php? t=930.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Azovskova O.V., Ivanchik N.V., Dekhnich A.V., Krechikova O.I. , Kozlov R.S. Pegasus Research Group. Dynamics of antibiotic resistance of the Streptococcus pyogenes strains in Russia in 1999-2009. Klin. Mikrobiol Antimikrob Khimiter, 2012, 14 (4): 309-321.</mixed-citation><mixed-citation xml:lang="en">Azovskova O.V., Ivanchik N.V., Dekhnich A.V., Krechikova O.I. , Kozlov R.S. Pegasus Research Group. Dynamics of antibiotic resistance of the Streptococcus pyogenes strains in Russia in 1999-2009. Klin. Mikrobiol Antimikrob Khimiter, 2012, 14 (4): 309-321.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
